Replies to post #229001 on Anavex Life Sciences Corp (AVXL)

[JWC3]

When asked at last CC in Dec 2019 about PDD, Missling said “We expect that both high and medium doses to be efficacious.”

At that point he was aware of the results for at least 84 patients of at least 18 weeks of open label dosing after they had completed the 14 trial regimen!